FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077700 [Registered on: 05/12/2024] Trial Registered Prospectively
Last Modified On: 05/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda
Yoga & Naturopathy
Process of Care Changes 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Study the effect of Trataka karma & CMC eyedrops in Computer Vision Syndrome in IT Professionals. 
Scientific Title of Study   A clinical study to evaluate the effect of Trataka karma in Computer Vision Syndrome in Information Technology professionals: A Randomized Controlled Trial. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Aishwarya Hariram Meshram 
Designation  PG Scholar 
Affiliation  Guide 
Address  Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Swasthavritta & Yoga Department, 15, Budhwar bazar, Hanuman nagar, Nagpur- 440024
Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Swasthavritta & Yoga Department, 15, Budhwar bazar, Hanuman nagar, Nagpur- 440024
Nagpur
MAHARASHTRA
440024
India 
Phone  8830475152  
Fax    
Email  meshramaishwarya06@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sapana A Ukey 
Designation  Assistant Professor 
Affiliation  Shri Ayurved Mahavidyalaya, Nagpur 
Address  Swasthavritta & Yoga Department, Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman nagar, Nagpur

Nagpur
MAHARASHTRA
440024
India 
Phone  9890242929  
Fax    
Email  drsapnaukey@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sapana A Ukey 
Designation  Assistant Professor 
Affiliation  Shri Ayurved Mahavidyalaya, Nagpur 
Address  Swasthavritta & Yoga Department, Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman nagar, Nagpur


MAHARASHTRA
440024
India 
Phone  9890242929  
Fax    
Email  drsapnaukey@gmail.com  
 
Source of Monetary or Material Support  
Shri Ayurveda Mahavidyalaya, Nagpur, Hanuman Nagar, Nagpur Maharashtra, India 440024 
 
Primary Sponsor  
Name  Dr Aishwarya Hariram Meshram 
Address  Swasthavritta and Yoga Department, Pakwasa Samanvay Rugnalaya, Shri Ayurveda Mahavidyalaya, Hanuman Nagar, Nagpur, Maharashtra, India 440024 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aishwara Meshram  Information Technology Firm  IT park, Nagpur
Nagpur
MAHARASHTRA 
8830475152

meshramaishwarya06@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Ethical Commitee of Shri Ayurved Mahavidyalaya, Nagpur  Approved 
Information Technology Firm  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  healthy participants will be screened with the help of Computer Vision Syndrome Questionnaire and Schirmers test and those who will have positive score will be taken as case and control. 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-Trataka karma (Procedure Reference: Hathayoga Pradipika 2/31-32 page no. Khemraj Shrikrishnadas Prakashan, Mumbai, Procedure details: Trataka karma will be performed once a day for one month. Madhya Trataka karma will be followed by patients.)
2Comparator Arm (Non Ayurveda)-Carboxymethycellulose 0.5% eyedropsCMC 0.5% eyedrops to be instilled in both the eyes in QID for 1 month.
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  Patients working in IT sector with screen time more than 4 hours a day for 3 months with or without the use of any spectacles.
Patients of CVS evaluated by Computer Vision Syndrome Questionnaire with score more than or equal to 6 and Schirmers test with score less than 15. 
 
ExclusionCriteria 
Details  Known hypersensitivity to study medications and those who had used any other topical ophthalmic medications within 14 days (other than tear substitutes).
History of any active ocular infection or allergy or surgery within 12 months or use of any contact lenses.
Patients of Sjogren syndrome and other autoimmune diseases.
Any systemic diseases like uncontrolled HTN or DM or congenital deformities or thyroid abnormalities or renal diseases or cardiac diseases and carcinoma will be excluded. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate and compare the efficacy of Trataka karma in Computer Vision Syndrome based on Computer Vision Syndrome Questionnaire.  Follow up will be taken on day 15 and 30. 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate & compare the efficacy of Trataka karma in Computer Vision Syndrome based on Schirmers test.  Follow up will be taken on day 15 & 30. 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   In the present study, total 64 participants will be taken for trial dividing them in 2 equal groups. Group A will receive the trial procedure ’Trataka karma’ and Group B will receive the already proven drug ’CMC 0.5% e/d’ Follow up will be taken on day- 0, 15 and 30. Result will be concluded based on assessment criteria. 
Close